Shingles Clinical Trials

A listing of Shingles medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Featured trial
Shingles / Flu Vaccine Clinical Study with Investigational COVID-19 Booster

Healthy volunteers to participate in a clinical research study for Shingles or Flu with an investigational COVID-19 booster.

booster
covid-19
  • 77 views
  • 11 Oct, 2021
  • 1 location
Featured trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People who have cancer tend to get sick more often. This is in part because of the cancer treatments they get. Because of this, they may get shingles

cancer
ibrutinib
chronic lymphocytic leukemia
acalabrutinib
lymphoma
  • 216 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Pain after Shingles (Post Herpetic Neuralgia) Research Study

Pain after Shingles (Post Herpetic Neuralgia) Research Study

  • 1566 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Do you suffer from Pain after Shingles (PHN)?

Do you suffer from Pain after Shingles (PHN)?

  • 1029 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

  • 598 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

  • 211 views
  • 25 Mar, 2021
  • 1 location
None
Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations

The pandemic caused by the novel coronavirus SARS-CoV-2 has resulted in substantial global morbidity and mortality including in Oklahoma and caused unprecedented interruptions in nearly all aspects of our lives. The population of the state of Oklahoma is at particular risk to SARS-CoV-2 due to its large rural population, strained …

  • 0 views
  • 14 May, 2021
  • 1 location
None
Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)

zoster account for 5 to 10% of patients. The remaining 50% of cases are classified as idiopathic. CIRIS, is the first prospective randomized, head to head study, comparing infliximab to

  • 0 views
  • 24 Jan, 2021
  • 1 location
None
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Background -DOCK8 deficiency is a genetic disorder that affects the immune system and can lead to severe recurrent infections and possible death from infections or certain types of cancers, including blood cancers. A stem cell transplant is a life-saving treatment for this condition. In this study we are evaluating the …

Accepts healthy volunteers
  • 16 views
  • 01 Dec, 2021
  • 1 location
None
Algorithms for Programming DBS Systems for ET

Deep brain stimulation (DBS) targeting the Vim thalamus (ventralis intermedius nucleus) is an FDA-approved neuromodulation therapy for treating postural and action tremor in individuals with essential tremor (ET). The success of this treatment, however, is highly dependent on the ability of clinicians to identify therapeutic stimulation settings through a laborious …

MRI
brain stimulation
intention tremor
  • 49 views
  • 24 Jan, 2021
  • 1 location